Compare Opendoor Technologies Inc (OPEN) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Opendoor Technologies Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? Opendoor Technologies Inc trades at $1.96 (market cap $2.05B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 2.5× Opendoor Technologies Inc's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Opendoor Technologies Inc for 33 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| OPEN | ORKA | |
|---|---|---|
Market Cap | $2.05B | $5.18B |
Volume | 27,619,294 | 490,798 |
Sector | Real Estate | Health |
52-Week High | $9.37 | $113.08 |
52-Week Low | $1.99 | $26.19 |
Typical Hold Time | 33 Days | 0 Days |
Enterprise Value | $3.12B | $4.31B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Opendoor Technologies trades at $2.11, down 86% from its peak, with bearish technical signals dominating. The company shows deteriorating fundamentals with revenue declining from $15.6B in 2022 to $4.4B in 2025 while net losses widened to -$1.3B. Recent earnings misses and negative profit margins contrast with analyst optimism, as the stock trades well below the $4.92 consensus target. The mortgage expansion initiative represents a potential growth catalyst amid challenging housing market conditions.
The outlook remains challenging with persistent losses and housing market sensitivity, though deep valuation discount and strategic initiatives offer speculative upside. Key risks include execution missteps, interest rate sensitivity, and competitive pressures in the iBuyer space. Investors face high volatility but potential for significant returns if the turnaround strategy succeeds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
